4:12 PM Abstract No. 306 Survival benefits of drug-eluting bead transarterial chemoembolization in Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma patients
The current Barcelona Clinic Liver Cancer (BCLC) guidelines recommend systemic therapy as the mainstay treatment for advanced stage (BCLC-C) Hepatocellular Carcinoma (HCC) while reserving Transarterial Chemoembolization for intermediate stage (BCLC-B). Our goal is to evaluate survival benefits of Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) in BCLC-C patients.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: T. Mai, F. Contreras, S. Venkat, P. Mohan, S. Bhatia Tags: Scientific Session 33 Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Radiology | Urology & Nephrology